Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC

INTRODUCTION: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the survival of colorectal cancer (CRC) patients with peritoneal metastases. Patient selection is key since this treatment is associated with high morbidity. Patients with peritoneal recurrence within 1 year af...

Descripción completa

Detalles Bibliográficos
Autores principales: Sluiter, Nina R., Rovers, Koen P., Salhi, Youssra, Vlek, Stijn L., Coupé, Veerle M. H., Verheul, Henk M. W., Kazemier, Geert, de Hingh, Ignace H. J. T., Tuynman, Jurriaan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028868/
https://www.ncbi.nlm.nih.gov/pubmed/29855834
http://dx.doi.org/10.1245/s10434-018-6539-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028868/
https://www.ncbi.nlm.nih.gov/pubmed/29855834
http://dx.doi.org/10.1245/s10434-018-6539-x

Ejemplares similares